Viewing data from:

DEFERIPRONE

ANDA

DEFERIPRONE | A208800 | TARO PHARMACEUTICAL INDUSTRIES LTD

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: FERRIPROX(TE code: AB)

API Supply Chain5 active DMFs1 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

APOTEX INCDEFERIPRONE

DMF 108671994

EMCURE PHARMACEUTICALS LTDDEFERIPRONE

DMF 216402008

TARO PHARMACEUTICAL INDUSTRIES LTDDEFERIPRONE

DMF 289832015

AARTI PHARMALABS LTDDEFERIPRONE

DMF 397662024

INDUSTRIALE CHIMICA SRLDEFERIPRONE

DMF 419162025

CADILA HEALTHCARE LTDInactiveDEFERIPRONE

DMF 149102000

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Mar 12, 2019	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — 500MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Feb 8, 2019

No patent or exclusivity listings for this strength.

#002 — 1GM

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Nov 22, 2023